secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0000721371-24-000054
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q4 revenue +12% to $59.9B, non-GAAP EPS $1.84 (+29%); raises FY25 guidance to $7.55-$7.70
--------------------------------------------------------------------------------

- Q4 revenue $59.9B (+12% YoY); GAAP EPS $0.96, non-GAAP EPS $1.84 (+29%).
- FY2024 revenue $226.8B (+11%), non-GAAP EPS $7.53 (+29%); operating cash flow record $3.8B.
- FY2025 non-GAAP EPS guidance raised to $7.55-$7.70 from at least $7.50.
- Pharmaceutical & Specialty Solutions segment profit +8% to $482M; GMPD profit $47M vs $7M YoY.
- GMPD segment profit improved $40M to $47M driven by net inflationary mitigation initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/0000721371-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/cah-20240814.htm
  HTML page:      https://secwatch.observer/filing/0000721371-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer